Evidence map›Paper›PMID 37391605›Full record

ArticleJournal of racial and ethnic health disparities2024

Vaccine Equity: Lessons Learned Exploring Facilitators and Barriers to COVID-19 Vaccination in Urban Black Communities.

Lalitha Parameswaran, Anna Jaysing, Helen Ding, Marc Wilkenfeld, Ranekka Dean, Kesi K Wilson, Olivia Frank, Ralf Duerr, Mark J Mulligan

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Journal of racial and ethnic health disparities, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Lalitha ParameswaranNew York University (NYU) Langone Vaccine Center, New York, NY, USA. Lalitha.Parameswaran@nyulangone.org.ORCID 0009-0000-2750-5357
Anna Jaysing *NYU Long Island School of Medicine, New York, NY, USA.
Helen Ding *NYU Long Island School of Medicine, New York, NY, USA.
Marc WilkenfeldDivision of Occupational/Environmental Medicine, Department of Medicine, NYU Long Island School of Medicine, New York, NY, USA.
Ranekka DeanDivision of Infectious Diseases and Immunology, Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA.
Kesi K WilsonNew York University (NYU) Langone Vaccine Center, New York, NY, USA.
Olivia FrankNew York University (NYU) Langone Vaccine Center, New York, NY, USA.
Ralf DuerrNew York University (NYU) Langone Vaccine Center, New York, NY, USA.
Mark J MulliganNew York University (NYU) Langone Vaccine Center, New York, NY, USA.
NYU Langone Health · USLong Island University · USNew York University · US

Funding

NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00014 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GARCIA-SASTRE, ADOLFO · 2021 to 2025
$62.6M
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU) - DMID 21-0012UM1AI148574 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Angelica Cifuentes Kottkamp, Anoma Nellore · 2020 to 2026
$23.9M
Division of Intramural Research, National Institute of Allergy and Infectious Diseases AI148574NIH HHS 75N93021C00014
6 · The paper itself

Abstract

COVID-19 vaccines were developed at unparalleled speed, but racial disparities persist in vaccine uptake. This is a cross-sectional survey that was conducted in mid-2021 in ambulatory clinics across Brooklyn, New York. The objectives of the study were to assess: knowledge of COVID-19, healthcare communication and access, attitudes including trust in the process of vaccine development and mistrust due to racial discrimination, and to determine the relationship of the above to vaccine receipt. 58 respondents self-identified as Black non-Hispanic and completed the survey: the majority were women (79%), <50 years old (65%), employed (66%), and had annual household income <$75,000 (59%). The majority reported having some health insurance (97%) and a regular place of healthcare (95%). 60% of respondents reported COVID-19 vaccination receipt. A significant percentage of the vaccinated group compared to the unvaccinated group scored higher on knowledge questions (91% vs. 65%; p = 0.018), felt it was important that others in the community get vaccinated (89% vs. 65%, p = 0.04), and trusted vaccine safety (86% vs. 35%; p < 0.0001) and effectiveness (88% vs. 48%; p < 0.001). The unvaccinated group reported a lower annual household income of <$75,000 (72% vs. 50%; p = 0.0002) and also differed by employment status (p = 0.04). Majority in both groups agreed that racial discrimination interferes with healthcare (78%). In summary, unvaccinated Black non-Hispanic respondents report significant concerns about vaccine safety and efficacy and have greater mistrust in the vaccine development process. The relationship between racial discrimination, mistrust, and vaccine hesitancy needs further study in order to improve vaccine uptake in this population.

Indexed as

Black or African AmericanCOVID-19COVID-19 VaccinesHealth Knowledge, Attitudes, PracticeUrban PopulationAdultCross-Sectional StudiesFemaleHealthcare DisparitiesHealth EquityHealth Services AccessibilityHumansMaleMiddle AgedNew York CityRacismCOVID-19 VaccinesBlackFacilitatorsNon-HispanicRacial discriminationVaccine hesitancy

Identifiers

PMID37391605
OpenAlexW4382771601

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.